Patents by Inventor Albert Sattin

Albert Sattin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tri-peptides for antidepressant applications
    Publication number: 20050233973
    Abstract: Provided are methods of treatment of neurological and neurobehavioral disorders, including antidepressants for use in treatment of depression and related disorders, utilizing pharmaceutical preparations including a manufactured peptide having the formula pGlu-R1-Pro, wherein R1 is Glu, Phe, Leu, Tyr, Lys or Val, and preferably Gly, Lys, Leu or Val, or pharmaceutically acceptable salts thereof, and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: September 13, 2004
    Publication date: October 20, 2005
    Inventors: Albert Sattin, Albert Pekary, Robert Lloyd
  • Tri-peptides for neurological and neurobehavioral applications
    Publication number: 20050009753
    Abstract: Provided are methods of treatment of neurological and neurobehavioral disorders utilizing pharmaceutical preparations including a manufactured peptide having the formula pGlu-R1-Pro, wherein R1 is Glu, Phe, Leu, Tyr or Val, or pharmaceutically acceptable salts thereof, and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: August 18, 2004
    Publication date: January 13, 2005
    Inventors: Albert Sattin, Albert Pekary, Robert Lloyd
  • Use of pyroglutamyl-glutamyl-prolyl amide (EEP) for neurological and neurobehavioral disorders
    Patent number: 6475989
    Abstract: A tri-peptide drug for treatment of neurological and neurobehavioral disorders of a mammal, such drug being derived from the following formula: pGlu-X-Pro-NH2, wherein the internal amino acid (X) is a non-histadine amino acid. Methods of treatment of neurological disorders using the tri-peptide, including as an adjunct, synergist or stand-alone therapy, in oral, parenteral, intranasal, transcutaneous, or rectal forms.
    Type: Grant
    Filed: October 9, 1998
    Date of Patent: November 5, 2002
    Inventors: Albert Sattin, Albert E. Pekary, Robert L. Lloyd
  • Tri-peptides for neurological and neurobehavior applications
    Publication number: 20020151502
    Abstract: Provided are pharmaceutical preparations including a manufactured peptide having the formula pGlu-R1-Pro, wherein R1 is Glu, Phe, Leu, Tyr or Val, or pharmaceutically acceptable salts thereof, and a pharmaceutically acceptable carrier, and methods of treatment of neurological and neurobehavioral disorders therewith.
    Type: Application
    Filed: November 14, 2001
    Publication date: October 17, 2002
    Inventors: Albert Sattin, Albert E. Pekary, Robert L. Lloyd